Page 1 | Search Results | Blood Neoplasia | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning models

Ahmet Celal Toprak, Mutlu Mete, Julia J. Shi, Daria V. Babushok, Carmelo Gurnari, Jaroslaw P. Maciejewski, Zoe Bass, Zehra Tombul, Carlos. I. A. Santos, Munevver N. Duran, Hussein Awada, Ibrahim Ibrahim, Alper Olcal, Yusuf Ozcan, Leslie Guerrero, Julio Alvarenga Thiebaud, Taha Bat

Blood Neoplasia (2025) 2 (4): 100163.

https://doi.org/10.1016/j.bneo.2025.100163

Published: 2025

Includes: Supplemental data

Journal Articles

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts

Stefania Leone, Francesco Grimaldi, Mara Memoli, Giulia Scalia, Annamaria Vincenzi, Maria Di Perna, Giuseppe Cerciello, Antonio Vassallo, Fabrizio Pane, Alessandra Picardi, Giuseppe Terrazzano, Giuseppina Ruggiero, Flavia Carriero, Valentina Rubino

Blood Neoplasia (2025) 2 (4): 100170.

https://doi.org/10.1016/j.bneo.2025.100170

Published: 2025

Includes: Supplemental data

Journal Articles

Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort

Rohiverth Guarecuco, Lisa Yuen, Maxwell Roth, Brandon J. Aubrey, Andrew M. Brunner, Robert P. Hasserjian

Blood Neoplasia (2025) 2 (4): 100162.

https://doi.org/10.1016/j.bneo.2025.100162

Published: 2025

Includes: Supplemental data

Journal Articles

A comparative assessment of molecular-based prognostic models in CMML

Luis E. Aguirre, Najla Al Ali, Somedeb Ball, Akriti G. Jain, David A. Sallman, Andrew T. Kuykendall, Alison R. Walker, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, Rami S. Komrokji

Blood Neoplasia (2025) 2 (4): 100116.

https://doi.org/10.1016/j.bneo.2025.100116

Published: 2025

Includes: Supplemental data

Journal Articles

SRSF2 mutations in CCUS, MDS and AML: a cross-entity study

Sandra Huber, Sarah Ochmann, Stephan Hutter, Veronika Ecker, Manja Meggendorfer, Gregor Hoermann, Torsten Haferlach, Claudia Haferlach, Isolde Summerer

Blood Neoplasia (2025) 2 (4): 100144.

https://doi.org/10.1016/j.bneo.2025.100144

Published: 2025

Includes: Supplemental data

Journal Articles

Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm

Suravi Raychaudhuri, Ted A. Gooley, Allegra Rasmussen, Kim Quach, Eva Gill, Anna B. Halpern, Jacob S. Appelbaum, Cristina M. Ghiuzeli, Paul C. Hendrie, Ryan D. Cassaday, Roland B. Walter, Mary-Elizabeth M. Percival

Blood Neoplasia (2025) 2 (3): 100085.

https://doi.org/10.1016/j.bneo.2025.100085

Published: 2025

Includes: Supplemental data

Journal Articles

Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions

Tamara Westover, Michael P. Walsh, Sherif Abdelhamed, Emily Xiong, Jing Ma, Guangchun Song, Melvin E. Thomas, III, Masayuki Umeda, Jamie L. Maciaszek, Jasmine C. Wong, Astrid Wintering, Lu Wang, Peter D. Emanuel, Mignon L. Loh, Sarah K. Tasian, Elliot Stieglitz, Jason R. Schwartz, Kevin M. Shannon, Jeffery M. Klco

Blood Neoplasia (2025) 2 (2): 100093.

https://doi.org/10.1016/j.bneo.2025.100093

Published: 2025

Includes: Supplemental data

Journal Articles

Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

Matthew R. M. Jotte, Angela Stoddart, Tanner C. Martinez, Raven Moten, Yuqing Xue, Molly K. Imgruet, Hunter Blaylock, Henna S. Nam, Bonnie Hu, Jermaine Austin, Ningfei An, Saira Khan, Sandeep K. Gurbuxani, Megan E. McNerney

Blood Neoplasia (2025) 2 (2): 100083.

https://doi.org/10.1016/j.bneo.2025.100083

Published: 2025

Includes: Supplemental data

Journal Articles

Adult leukemia in Florida 2010-2019: diverse, aging population as an indicator for the United States

Ming S. Lee, Rebecca E. Kaiser, Christopher D. Armstrong, David B. Dukenik, Nancy S. Elliott, Raymond R. Balise, Justin M. Watts, Mikkael A. Sekeres, Erin N. Kobetz, Justin Taylor

Blood Neoplasia (2025) 2 (2): 100078.

https://doi.org/10.1016/j.bneo.2025.100078

Published: 2025

Journal Articles

Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm

Zhuoer Xie, Najla Al Ali, Ling Zhang, Peter Papenhausen, Virginia Olivia Volpe, Onyee Chan, Andrew Kuykendall, Seongseok Yun, Alison Walker, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman, Rami S. Komrokji

Blood Neoplasia (2025) 2 (2): 100062.

https://doi.org/10.1016/j.bneo.2024.100062

Published: 2025

Includes: Supplemental data

Journal Articles

Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level

Blood Neoplasia (2024) 1 (3): 100021.

https://doi.org/10.1016/j.bneo.2024.100021

Published: 2024

Includes: Supplemental data

Journal Articles

Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML

Samuel Urrutia, Prithviraj Bose, Yesid Alvarado, Gautam Borthakur, Farhad Ravandi, Naval Daver, Naveen Pemmaraju, Elias Jabbour, Koichi Takahashi, Tapan Kadia, Courtney DiNardo, Steven Kornblau, Rashmi Kanagal-Shamanna, Xuelin Huang, Kristy Bodden, Hagop Kantarjian, Guillermo Garcia-Manero

Blood Neoplasia (2024) 1 (2): 100008.

https://doi.org/10.1016/j.bneo.2024.100008

Published: 2024

Includes: Supplemental data

Journal Articles

Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells

Pedro Luis Moura, Yasuhito Nannya, Affaf Aliouat, Isabel Juliana Hofman, Teresa Mortera-Blanco, Tetsuichi Yoshizato, Ryunosuke Saiki, Masahiro M. Nakagawa, Maria Creignou, Ann-Charlotte Björklund, Gunilla Walldin, Indira Barbosa, Monika Jansson, Francesca Grasso, Edda M. Elvarsdottir, Petter S. Woll, Sten Eirik W. Jacobsen, Seishi Ogawa, Eva Hellström-Lindberg

Blood Neoplasia (2024) 1 (2): 100011.

https://doi.org/10.1016/j.bneo.2024.100011

Published: 2024

Includes: Supplemental data

Journal Articles

Comparison of TP53 mutations in myelodysplasia and acute leukemia suggests divergent roles in initiation and progression

Ashwini Jambhekar, Emily E. Ackerman, Berk A. Alpay, Galit Lahav, Scott B. Lovitch

Blood Neoplasia (2024) 1 (1): 100004.

https://doi.org/10.1016/j.bneo.2024.100004

Published: 2024

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Date

Availability

Predicting secondary myeloid neoplasms in acquired aplastic anemia using machine learning models

Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts

Application of the International Working Group MDS molecular taxonomy classes to a single institution cohort

A comparative assessment of molecular-based prognostic models in CMML

SRSF2 mutations in CCUS, MDS and AML: a cross-entity study

Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm

Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions

Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance

Adult leukemia in Florida 2010-2019: diverse, aging population as an indicator for the United States

Clinical correlation and prognostic impact of cytogenetic clone size for myelodysplastic syndromes/neoplasm

Instructive interaction between myelodysplastic hematopoiesis and the bone marrow microenvironment at the single-cell level

Prospective performance of the IWG-2023 criteria and IPSS-M in a phase 2 trial of guadecitabine for higher-risk MDS or CMML

Competition of dual SF3B1 mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells

Comparison of TP53 mutations in myelodysplasia and acute leukemia suggests divergent roles in initiation and progression

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only